These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17919858)

  • 21. Design and utilization of the drug-excipient chemical compatibility automated system.
    Thomas VH; Naath M
    Int J Pharm; 2008 Jul; 359(1-2):150-7. PubMed ID: 18486368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selection of excipients for extended release formulations of glipizide through drug-excipient compatibility testing.
    Verma RK; Garg S
    J Pharm Biomed Anal; 2005 Jul; 38(4):633-44. PubMed ID: 15967291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-excipient compatibility testing-Identification and characterization of degradation products of phenylephrine in several pharmaceutical formulations against the common cold.
    Douša M; Gibala P; Havlíček J; Plaček L; Tkadlecová M; Břicháč J
    J Pharm Biomed Anal; 2011 Jul; 55(5):949-56. PubMed ID: 21481557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selection of solid dosage form composition through drug-excipient compatibility testing.
    Serajuddin AT; Thakur AB; Ghoshal RN; Fakes MG; Ranadive SA; Morris KR; Varia SA
    J Pharm Sci; 1999 Jul; 88(7):696-704. PubMed ID: 10393567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stability indicating validated HPLC method for quantification of levothyroxine with eight degradation peaks in the presence of excipients.
    Shah RB; Bryant A; Collier J; Habib MJ; Khan MA
    Int J Pharm; 2008 Aug; 360(1-2):77-82. PubMed ID: 18524511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of microcalorimetry in determination of stability of enalapril maleate and enalapril maleate tablet formulations.
    Simoncic Z; Zupancic P; Roskar R; Gartner A; Kogej K; Kmetec V
    Int J Pharm; 2007 Sep; 342(1-2):145-51. PubMed ID: 17597314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stability of amlodipine besylate and atenolol in multi-component tablets of mono-layer and bi-layer types.
    Aryal S; Skalko-Basnet N
    Acta Pharm; 2008 Sep; 58(3):299-308. PubMed ID: 19103566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solid state compatibility studies with tablet excipients using non thermal methods.
    Liltorp K; Larsen TG; Willumsen B; Holm R
    J Pharm Biomed Anal; 2011 Jun; 55(3):424-8. PubMed ID: 21411259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of in vitro release rate and in vivo absorption characteristics of four metoprolol tartrate immediate-release tablet formulations.
    Rekhi GS; Eddington ND; Fossler MJ; Schwartz P; Lesko LJ; Augsburger LL
    Pharm Dev Technol; 1997 Feb; 2(1):11-24. PubMed ID: 9552427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative evaluation of two direct compression lactose grades for pyridoxine hydrochloride tablets.
    Aly SA; Udeala OK
    Pharmazie; 1988 Mar; 43(3):188-90. PubMed ID: 3380861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new esomeprazole packet (sachet) formulation for suspension: in vitro characteristics and comparative pharmacokinetics versus intact capsules/tablets in healthy volunteers.
    Bladh N; Blychert E; Johansson K; Backlund A; Lundin C; Niazi M; Pettersson G; Fjellman M
    Clin Ther; 2007 Apr; 29(4):640-9. PubMed ID: 17617287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of pharmaceutical excipients on quinapril hydrochloride stability.
    Stanisz B
    Acta Pol Pharm; 2005; 62(3):189-93. PubMed ID: 16193811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrating tristimulus colorimetry into pharmaceutical development for color selection and physical appearance control: a quality-by-design approach.
    Hetrick EM; Vannoy J; Montgomery LL; Pack BW
    J Pharm Sci; 2013 Aug; 102(8):2608-21. PubMed ID: 23728824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple-layer compression-coated tablets: formulation and humidity studies of novel chewable amoxicillin/clavulanate tablet formulations.
    Wardrop J; Jaber AB; Ayres JW
    Drug Dev Ind Pharm; 1998 Aug; 24(8):729-36. PubMed ID: 9876520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of two dextrose-based directly compressible excipients.
    Olmo IG; Ghaly ES
    Drug Dev Ind Pharm; 1998 Aug; 24(8):771-8. PubMed ID: 9876525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanical properties of excipients do not affect polymer matrix formation.
    Chatterjee L; Rades T; Tucker IG
    Int J Pharm; 2010 Jan; 384(1-2):87-92. PubMed ID: 19819317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RP-HPLC method for simultaneous estimation of bisoprolol fumarate and hydrochlorothiazide in tablet formulation.
    Joshi SJ; Karbhari PA; Bhoir SI; Bindu KS; Das C
    J Pharm Biomed Anal; 2010 Jul; 52(3):362-71. PubMed ID: 19926421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification, isolation and characterization of new impurity in rabeprazole sodium.
    Rao PS; Ray UK; Gupta PB; Rao DV; Islam A; Rajput P; Mukkanti K
    J Pharm Biomed Anal; 2010 Aug; 52(4):620-4. PubMed ID: 20153594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Photoreactivity of biologically active compounds. XVIII. Photostability of ofloxacin in the solid state and in a tablet formulation.
    Tønnesen HH; Brunsvik A; Løseth K; Bergh K; Gederaas OA
    Pharmazie; 2007 Feb; 62(2):105-11. PubMed ID: 17341028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.